GB1153792A - Pharmaceutical Compositions - Google Patents
Pharmaceutical CompositionsInfo
- Publication number
- GB1153792A GB1153792A GB4132566A GB4132566A GB1153792A GB 1153792 A GB1153792 A GB 1153792A GB 4132566 A GB4132566 A GB 4132566A GB 4132566 A GB4132566 A GB 4132566A GB 1153792 A GB1153792 A GB 1153792A
- Authority
- GB
- United Kingdom
- Prior art keywords
- nhr
- compositions
- hydrogen
- chlorophenyl
- pharmaceutical compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 abstract 2
- 125000006527 (C1-C5) alkyl group Chemical group 0.000 abstract 1
- NIGWMJHCCYYCSF-UHFFFAOYSA-N Fenclonine Chemical compound OC(=O)C(N)CC1=CC=C(Cl)C=C1 NIGWMJHCCYYCSF-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 229940082988 antihypertensives serotonin antagonists Drugs 0.000 abstract 1
- 239000003420 antiserotonin agent Substances 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 235000009508 confectionery Nutrition 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 239000007937 lozenge Substances 0.000 abstract 1
- -1 p-chlorophenyl compound Chemical class 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 150000004717 pyruvic acids Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 239000007921 spray Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 235000020357 syrup Nutrition 0.000 abstract 1
- 239000006188 syrup Substances 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/36—One oxygen atom
- C07D263/42—One oxygen atom attached in position 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
- C07C59/56—Unsaturated compounds containing hydroxy or O-metal groups containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/88—Unsaturated compounds containing keto groups containing halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49533765A | 1965-10-12 | 1965-10-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1153792A true GB1153792A (en) | 1969-05-29 |
Family
ID=23968253
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB4132566A Expired GB1153792A (en) | 1965-10-12 | 1966-09-15 | Pharmaceutical Compositions |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR5734M (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) |
GB (1) | GB1153792A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113967416A (zh) * | 2021-10-29 | 2022-01-25 | 新疆医科大学第四附属医院 | 一种高浓度对氯苯丙氨酸的溶解方法及应用 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0000382D0 (sv) | 2000-02-07 | 2000-02-07 | Astrazeneca Ab | New process |
-
1966
- 1966-09-15 GB GB4132566A patent/GB1153792A/en not_active Expired
- 1966-09-27 FR FR77832A patent/FR5734M/fr not_active Expired
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113967416A (zh) * | 2021-10-29 | 2022-01-25 | 新疆医科大学第四附属医院 | 一种高浓度对氯苯丙氨酸的溶解方法及应用 |
Also Published As
Publication number | Publication date |
---|---|
FR5734M (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1968-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU906402D0 (en) | Process for producing tricyclic carbapeneme derivatives an pharmaceutical preparatives containing these compounds as active substance | |
ES468173A1 (es) | Un procedimiento para la preparacion de derivados de morfina | |
YU63689A (en) | Acyl derivatives | |
YU54189A (en) | Process for obtaining cephem derivatives and midproducts for the same | |
IE830411L (en) | 4``-epi-erythromycin a | |
EP0188254A3 (en) | New cephem compounds, processes for preparation thereof and pharmaceutical compositions containing them | |
IE38979L (en) | Tetrazolyl - quinoxalinecarboxamide derivatives | |
GB1456627A (en) | Pyridobenzodiazepinones | |
ES468170A1 (es) | Un procedimiento para la preparacion de un nuevo derivado demorfina | |
GB1153792A (en) | Pharmaceutical Compositions | |
MY101993A (en) | Cephalosporin ester derivatives their production and use. | |
ES466192A1 (es) | Procedimiento para la obtencion de derivados de la isoqui- noleina. | |
GB1252286A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
ES474785A1 (es) | Un procedimiento para la preparacion de compuestos derivadosde 1-(naftiletil)imidazol | |
GB1262292A (en) | Novel thiazoline derivatives, the preparation thereof and compositions containing the same | |
IE34590L (en) | Phenylethanolamine derivatives | |
GB1381090A (en) | 3-alkylamino-alpha-aminomethyl-4-hydroxybenzyl alcohols | |
GB1468079A (en) | Ethanolamine derivatives | |
ES8304923A1 (es) | Un procedimiento para la preparacion de un peptido. | |
IL72709A0 (en) | 7alpha-substituted 3-oxo-17alpha-pregn-4-ene-21,17-carbolactones,process for their production,and pharmaceutical preparations containing same | |
GB1420758A (en) | Anti-ulcer compositions | |
GB1472502A (en) | Sulphonylurea derivatives | |
EP0198190A3 (en) | Compounds having antiplatelet aggregation activity, a process for the preparation thereof and pharmaceutical compositions containing them | |
GB1231613A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
GB1330930A (en) | Thiazole derivatives and a process for the manufacture thereof |